Features, Treatment, and Outcomes of Macrophage Activation Syndrome in Childhood‐Onset Systemic Lupus Erythematosus

Objective To describe the features and treatment of macrophage activation syndrome (MAS) in a single‐center cohort of patients with childhood‐onset systemic lupus erythematosus (SLE), and to compare childhood‐onset SLE manifestations and outcomes between those with and those without MAS. Methods We...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Arthritis & rheumatology (Hoboken, N.J.) N.J.), 2018-04, Vol.70 (4), p.616-624
Hauptverfasser:	Borgia, R. Ezequiel, Gerstein, Maya, Levy, Deborah M., Silverman, Earl D., Hiraki, Linda T.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adrenal Cortex Hormones - therapeutic use Age of Onset Autoimmune diseases Cell activation Central nervous system Child Children Chronic conditions Continuity (mathematics) Corticoids Corticosteroids Damage Demographics Female Fever Hospitalization - statistics & numerical data Humans Intensive Care Units, Pediatric - statistics & numerical data Kaplan-Meier Estimate Lupus Lupus Erythematosus, Systemic - immunology Macrophage Activation Syndrome - drug therapy Macrophage Activation Syndrome - immunology Macrophage Activation Syndrome - mortality Macrophages Male Mortality Patients Prospective Studies Steroid hormones Steroids Survival analysis Systemic lupus erythematosus
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!